Dr Roger Henderson examines a 23-year follow-up of a European study that assessed the effects of prostate-specific antigen testing on prostate cancer mortality.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.